Overview

Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants

Status:
Completed
Trial end date:
2016-09-12
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and clinical utility of the active, SSEC fentanyl 40 micrograms (mcg) for the management of acute, postoperative pain in pediatric participants.
Phase:
Phase 3
Details
Lead Sponsor:
The Medicines Company
Collaborator:
Incline Therapeutics, Inc.
Treatments:
Fentanyl